Drug controller approves Phase 1, 2 trials of India’s first COVID-19 vaccine candidate

Human clinical trials in India are scheduled to start by July 2020

Drug controller approves Phase 1, 2 trials of India’s first COVID-19 vaccine candidate

Photo for representation only.

Aditi Tandon
Tribune News Service
New Delhi, June 30

India’s first COVID-19 Vaccine—COVAXIN, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, on Tuesday received the approval for phase one and two human clinical trials from the Drug Controller General of India.

Bharat Biotech has developed COVAXIN in association with ICMR’s National Institute of Virology (NIV) Pune.

The SARS-CoV-2 strain was isolated at NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in Bharat Biotech’s Bio-Safety Level-3 High Containment facility located in Genome Valley, Hyderabad.

The Drug Controller General of India granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response.

Human clinical trials in India are scheduled to start by July 2020.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: “We are proud to announce COVAXIN, India’s first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine. The proactive support and guidance from CDSCO have enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform.”

Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies.

Results from these studies have been promising and show extensive safety and effective immune responses.

Top Stories

Highest ever single-day Covid spike in India with 1.84 lakh new cases

Highest ever single-day Covid spike in India with 1.84 lakh new cases

The death toll increases to 1,72,085 with 1,027 new fataliti...

CBSE exams: Modi to meet education minister, officials today

CBSE exams: Modi to meet education minister, officials today

Class 10 and 12 exams are set to begin from May 4

Capt writes to Centre seeking postponement of CBSE board exams

Capt writes to Centre seeking postponement of CBSE board exams

The Punjab Board has broadly aligned its examination dates w...

India under Modi more likely to respond with military force to Pak provocations: US intelligence report

India under Modi more likely to respond with military force to Pak provocations: US intelligence report

The Office of the Director of National Intelligence says thi...

China-India border tensions remain high despite some force pullbacks: US intelligence report

China-India border tensions remain high despite some force pullbacks: US intelligence report

The Office of the Director of National Intelligence says thi...

Cities

View All